Cancer
This page brings together the European Medicines Agency's (EMA) latest information on cancer.
It lists the following:
- The newest and recently updated medicines authorised for cancer in the European Union
- EMA's latest cancer-related news announcements
- EMA's upcoming events on cancer-related topics
We are currently unable to display the new and recently updated medicines authorised for cancer due to a technical error. We are working to resolve the issue as soon as possible. We apologise for any inconvenience caused.
Latest news
EMA’s human medicines committee (CHMP) recommended eight medicines for approval at its April 2024 meeting.
NewsHumanCOVID-19Medicines
EMA’s human medicines committee (CHMP) recommended 12 medicines for approval at its March 2024 meeting.
NewsHumanMedicinesReferrals
EMA’s human medicines committee (CHMP) recommended 10 medicines for approval at its February 2024 meeting.
NewsHumanMedicinesReferralsVaccines
EMA’s human medicines committee (CHMP) recommended seven medicines for approval at its December 2023 meeting.
NewsHumanMedicinesReferrals
Events of interest
EMA and EORTC organise a multi-stakeholder workshop on soft tissue and bone sarcoma.
Online
European Medicines Agency, Amsterdam, the Netherlands
Start date:
24 May 2024
End date:
24 May 2024
EventHumanMedicines
Online
European Medicines Agency, Amsterdam, the Netherlands
Start date:
24 October 2024
End date:
25 October 2024
EventHumanMedicinesPaediatrics